Indeed, the VEGF signal‐transduction pathway has been implicated in breast cancer pathogenesis, and anti‐VEGF therapy acting on tumour vasculature has been used for breast cancer therapy 5. This evidence concerns the gene VEGFA and breast carcinoma.